15 June 2023 | Thursday | News
Image Source | Public Domain
The repurchases will be executed through one or more individual forward transactions, expected to be entered into in the second and/or the third quarter of 2023, in accordance with the Market Abuse Regulation and within the limits of the authorization granted by the company’s General Meeting of Shareholders on May 9, 2023. Philips expects to take delivery of the shares in 2024 and 2025. Further details will be available via this link.
© 2024 Biopharma Boardroom. All Rights Reserved.